Figure from article: Too late for prevention,...
 
KEYWORDS
TOPICS
ABSTRACT
Cervical cancer is one of the most common gynecological malignancies worldwide. The main risk factor is persistent infection with oncogenic types of human papillomavirus (HPV), particularly types 16 and 18. The disease is rarely observed in young women and progresses slowly. In its early stages is often asymptomatic, which may delay diagnosis and worsen prognosis. This paper presents the case of a 28-year-old woman who reported recurrent intermenstrual bleeding and postcoital vaginal spotting. Initial clinical evaluation revealed a palpable mass and tenderness in the region of the right adnexa, raising suspicion of a tumor in that area, which was confirmed by ultrasonographic examination. Further imaging and histopathological evaluation confirmed invasive squamous cell carcinoma of the cervix, with infiltration of adjacent structures and a concurrent neoplastic lesion of the right adnexa what made it inoparable. This case highlights the importance of regular cervical cancer screening and timely diagnostic evaluation, particularly in younger women, whose symptoms may be nonspecific. Early detection significantly improves the chances of effective treatment and long-term survival.
REFERENCES (20)
1.
Fowler J.R., Maani E.V., Dunton C.J., Gasalberti D.P., Jack B.W. Cervical Cancer. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2023, https://www.ncbi.nlm.nih.gov/b... [accessed on 11 July 2025].
 
2.
Profilaktyka raka szyjki macicy. Centrum e-Zdrowia [ed.] Pacjent gov, 14.11.2019 [online] https://pacjent.gov.pl/program... [accessed on 11 July 2025].
 
3.
Seweryn M., Leszczyńska A., Jakubowicz J., Banaś T. Cervical cancer in Poland — epidemiology, prevention, and treatment pathways. Oncol. Clin. Pract., published online 2024 Jul 10, doi: 10.5603/ocp.100857.
 
4.
Mimo reform, kompleksowej opieki onkologicznej wciąż brak / Informacje o wynikach kontroli. Najwyższa Izba Kontroli, 25 lutego 2025 [online] https://www.nik.gov.pl/najnows... [accessed on 11 July 2025].
 
5.
International Collaboration of Epidemiological Studies of Cervical Cancer. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int. J. Cancer 2007; 120(4): 885–891, doi: 10.1002/ijc.22357. Erratum in: Int. J. Cancer 2007; 120(11): 2525. Berrington de González, Amy [removed]; Green, Jane [removed].
 
6.
International Collaboration of Epidemiological Studies of Cervical Cancer; Appleby P., Beral V., Berrington de González A., Colin D., Franceschi S., Goodill A. et al. Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int. J. Cancer 2006; 118(6): 1481–1495, doi: 10.1002/ijc.21493.
 
7.
Castellsagué X., Díaz M., de Sanjosé S., Muñoz N., Herrero R., Franceschi S. et al. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J. Natl. Cancer Inst. 2006; 98(5): 303–315, doi: 10.1093/jnci/djj067.
 
8.
Singh G.K., Miller B.A., Hankey B.F., Edwards B.K. Area Socioeconomic Variations in U.S. Cancer Incidence, Mortality, Stage, Treatment, and Survival, 1975–1999. NCI Cancer Surveillance Monograph Series, Number 4. Bethesda, MD: National Cancer Institute, 2003. NIH Publication No. 03-5417.
 
9.
Yoo W., Kim S., Huh W.K., Dilley S., Coughlin S.S., Partridge E.E. et al. Recent trends in racial and regional disparities in cervical cancer incidence and mortality in United States. PLoS One 2017; 12(2): e0172548, doi: 10.1371/journal.pone.0172548.
 
10.
Yu L., Sabatino S.A., White M.C. Rural-urban and racial/ethnic disparities in invasive cervical cancer incidence in the United States, 2010–2014. Prev. Chronic Dis. 2019; 16: E70, doi: 10.5888/pcd16.180447.
 
11.
Hemminki K., Chen B. Familial risks for cervical tumors in full and half siblings: etiologic apportioning. Cancer Epidemiol. Biomarkers Prev. 2006; 15(7): 1413–1414, doi: 10.1158/1055-9965.EPI-05-0933.
 
12.
Schiffman M., Castle P.E., Jeronimo J., Rodriguez A.C., Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007; 370(9590): 890–907, doi: 10.1016/S0140-6736(07)61416-0.
 
13.
Adegoke O., Kulasingam S., Virnig B. Cervical cancer trends in the United States: a 35-year population-based analysis. J. Womens Health 2012; 21(10): 1031–1037, doi: 10.1089/jwh.2011.3385.
 
14.
Stolnicu S., Soslow R.A. Squamous and glandular epithelial tumors of the cervix: A pragmatical review emphasizing emerging issues in classification, diagnosis, and staging. Surg. Pathol. Clin. 2022; 15(2): 369–388, doi: 10.1016/j.path.2022.02.010.
 
15.
Albores-Saavedra J., Gersell D., Gilks C.B., Henson D.E., Lindberg G., Santiago H. et al. Terminology of endocrine tumors of the uterine cervix: results of a workshop sponsored by the College of American Pathologists and the National Cancer Institute. Arch. Pathol. Lab. Med. 1997; 121(1): 34–39.
 
16.
Dursun P., Gultekin M., Bozdag G., Usubutun A., Uner A., Celik N.Y. et al. Primary cervical lymphoma: report of two cases and review of the literature. Gynecol. Oncol. 2005; 98(3): 484–489, doi: 10.1016/j.ygyno.2005.04.040.
 
17.
Kendrick J.E. 4th, Straughn J.M. Jr. Two cases of non-Hodgkin’s lymphoma presenting as primary gynecologic malignancies. Gynecol. Oncol. 2005; 98(3): 490–492, doi: 10.1016/j.ygyno.2005.04.033.
 
18.
Wright J.D., Rosenblum K., Huettner P.C., Mutch D.G., Rader J.S., Powell M.A. et al. Cervical sarcomas: an analysis of incidence and outcome. Gynecol. Oncol. 2005; 99(2): 348–351, doi: 10.1016/j.ygyno.2005.06.021.
 
19.
Bhatla N., Aoki D., Sharma D.N., Sankaranarayanan R. Cancer of the cervix uteri. Int. J. Gynaecol. Obstet. 2018; 143 Suppl 2: 22–36, doi: 10.1002/ijgo.12611. Erratum in: Int. J. Gynaecol. Obstet. 2024; 164(3): 1229–1230, doi: 10.1002/ijgo.15395.
 
20.
Corrigendum to “Revised FIGO staging for carcinoma of the cervix uteri” [Int J Gynecol Obstet 145(2019) 129–135]. Int. J. Gynaecol. Obstet. 2019; 147(2): 279–280, doi: 10.1002/ijgo.12969. Erratum for: Int. J. Gynaecol. Obstet. 2019; 145(1): 129–135, doi: 10.1002/ijgo.12749.
 
eISSN:1734-025X
Journals System - logo
Scroll to top